Food and drug administration approval process for dermatology drugs in the United States
Aim: The purpose of this review is to elucidate the steps involved in the FDA’s approval of new dermatology drugs. Methods: To help illustrate the process of drug approval, we use examples from the recent approval of dupilumab (REGN668; Regeneron Pharmaceuticals). Results: In general, new dermatolog...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2018-08-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/09546634.2018.1425361 |